ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Nobiletin mitigates NAFLD via lipophagy and inflammation

Yang, Xushan; Deng, Yudi; Tu, Yali; Feng, Dongliang; Liao, Wenzhen*南方医科大学
Food & Function2022-10-3DOI: 10.1039/d2fo01682f
6被引19阅读
引用收藏
分享

摘要

Nonalcoholic fatty liver disease (NAFLD), an increasingly serious health issue around the world, is characterized as a lipid metabolic disorder without any satisfactory treatment. Nobiletin (NOB), a citrus flavonoid, is considered a promising candidate for NAFLD prevention although there is limited research towards its exact mechanism. In this study, the preventative effect of NOB on NAFLD was investigated using high fat diet-fed ApoE(-/-) mice and free fatty acid-treated HepG2 cells. The results of hematoxylin and eosin staining of liver sections revealed that L-NOB (50 mg kg(-1) d(-1) NOB), M-NOB (100 mg kg(-1) d(-1) NOB) and H-NOB (200 mg kg(-1) d(-1) NOB) could significantly ameliorate NAFLD. Further exploration illustrated that NOB alleviated hepatic steatosis mainly via TFEB-mediated lysosomal biogenesis and lipophagy. Besides, NOB could mitigate NLRP3 inflammasome assembly and modulate M1/M2 macrophage polarization in vivo and in vitro. The mechanisms above allowed NOB to attenuate NAFLD, but their close association needed further investigation. Our research not only illustrated NOB as a potential candidate for NAFLD prevention, but also provided new insight into the pathogenic mechanisms of NAFLD development.

学科与关键词

关键词
FATTY LIVER-DISEASENONALCOHOLIC STEATOHEPATITIS NASHINSULIN-RESISTANCEAUTOPHAGYPATHOGENESISACTIVATIONOBESITY
相关
加载中…
  • A lipidomic study: Nobiletin ameliorates hepatic steatosis through regulation of lipid alternation
    Yang, Xushan; Sun, Linye; Feng, Dongliang; Deng, Yudi; Liao, Wenzhen*Journal of Nutritional Biochemistry, 2023, 118: 109353.被引 3
  • Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative Stress
    Li, Yunjia; Yang, Menghan; Lin, Haiyan; Yan, Weixin; Deng, Guanghui; Ye, Haixin; Shi, Hao; Wu, Chaofeng; Ma, Guoliang; Xu, Shu; Tan, Qinxiang*; Gao, Zhuowei*; Gao, Lei*Frontiers in Pharmacology, 2022, 12: 801730.被引 11
  • Anti-atherosclerosis effect of nobiletin via PINK1/Parkin-mediated mitophagy and NLRP3 inflammasome signaling pathway
    Deng, Yudi; Tu, Yali; Yang, Xushan; Liao, Xiaoshan; Xia, Zijun; Liao, Wenzhen*Journal of Functional Foods, 2023, 100: 105369.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Food & Function
发表日期
2022-10-03
卷期
第 13 卷, 第 19 期
页码
10186-10199
DOI
10.1039/d2fo01682f
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81973013]; Guangdong Key RD Program [2019B020210002]; Guangdong Basic and Applied Basic Research Foundation [2018030310301, 2020A1515010594]; Regular Institutions of Higher Learning Characteristic Innovation Projects of Guangdong Province [2018KTSCX030]

作者

  • Y

    Yang, Xushan (第一作者)

    southern med univ

  • D

    Deng, Yudi

    southern med univ

查看全部 5 位作者收起作者
  • T

    Tu, Yali

    southern med univ

  • F

    Feng, Dongliang

    southern med univ

  • L

    Liao, Wenzhen (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417